Announcements Trials
Browse Landscape

Phase

Phase 1 5

Status

Completed 4Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Myelodysplastic Syndromes 30Leukemia, Myeloid, Acute 30Multiple Myeloma 24Lymphoma, Non-Hodgkin 24Hodgkin Disease 24Lymphoma 21Leukemia 21Graft vs Host Disease 21Leukemia, Lymphocytic, Chronic, B-Cell 20Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Myeloproliferative Disorders 15Lymphoma, Mantle-Cell 15Neoplasms 14Tuberous Sclerosis 13Lymphoma, Large B-Cell, Diffuse 13Hematologic Neoplasms 12Burkitt Lymphoma 12Primary Myelofibrosis 11Lymphoma, Follicular 11Breast Neoplasms 11Waldenstrom Macroglobulinemia 10Sarcoma 10Recurrence 10Neoplasms, Plasma Cell 10Neoplasm Metastasis 10Lymphoma, B-Cell, Marginal Zone 10Leukemia, Myelomonocytic, Chronic 10Prostatic Neoplasms 9Lymphangioleiomyomatosis 9

Interventions

Surveys and Questionnaires 7Standard of Care 5Sirolimus 5Bevacizumab 5temsirolimus 4Interviews as Topic 4Paclitaxel 3olaparib 2Vorinostat 2Olanzapine 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Everolimus 2Erlotinib Hydrochloride 2Dasatinib 2Cetuximab 2zaleplon 1vistusertib 1tilsotolimod 1pazopanib 1olanzapine-fluoxetine combination 1nimotuzumab 1liposomal doxorubicin 1capivasertib 1apatinib 1Videotape Recording 1Vemurafenib 1Valproic Acid 1Trastuzumab 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Advanced Cancer × Sirolimus × Clear all
NCT01087554 2026-01-16

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
249 enrolled

Advanced Cancer

NCT00940381 2015-11-18

Sirolimus and Cetuximab in Advanced Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
165 enrolled

Advanced Cancer

NCT01054313 2015-10-07

Docetaxel and Sirolimus in Patients With Advanced Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
103 enrolled

Advanced Cancer

NCT00707135 2014-01-17

Rapamycin in Advanced Cancers

University of Chicago

Phase 1 Completed
40 enrolled

Advanced Cancer

NCT00708591 2014-01-17

Study of Rapamycin Plus Ketoconazole in Advanced Cancers

University of Chicago

Phase 1 Completed
57 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡